Comparison of an industry-derived LCx Chlamydia pneumoniae PCR research kit to in-house assays performed in five laboratories.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Wood, Billie Jo
Journal titleJournal of clinical microbiology
Publication Begin page2357
Publication End page62
MetadataShow full item record
AbstractIn a multicenter comparison of PCR assays utilizing 120 quantitated samples of 16 Chlamydia pneumoniae isolates, an LCx research-use-only (RUO) PCR developed by Abbott Laboratories demonstrated 100% sensitivity on 48 samples with >1 copy of DNA per microl of specimen. The sensitivities of five in-house PCR assays ranged from 54 to 94% for the same samples. All six assays showed decreased sensitivities as the DNA copy numbers of the samples decreased. Overall, sensitivities ranged from 68% for the LCx PCR assay to 29% for one of the in-house tests. The LCx RUO PCR and three of the five in-house PCR tests reported no false positives with the 24 negative samples. Increasing the number of replicates tested increased the sensitivities of all of the assays, including the LCx PCR. The LCx RUO assay showed high reproducibility for a single technologist and between technologists, with a kappa agreement of 0.77. The within-center agreements of the five in-house PCR tests varied from 0.19 to 0.74 on two challenges of 60 specimens 1 month apart. The LCx C. pneumoniae RUO PCR shows excellent potential for use in clinical studies, which could enable standardization of results in the field.
CitationChernesky M, Smieja M, Schachter J, Summersgill J, Schindler L, Solomon N, Campbell K, Campbell L, Cappuccio A, Gaydos C, Chong S, Moncada J, Phillips J, Jang D, Wood BJ, Petrich A, Hammerschlag M, Cerney M, Mahony J. Comparison of an industry-derived LCx Chlamydia pneumoniae PCR research kit to in-house assays performed in five laboratories. J Clin Microbiol. 2002 Jul;40(7):2357-62. doi: 10.1128/JCM.40.7.2357-2362.2002. PMID: 12089248; PMCID: PMC120594.
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International
- Analytical sensitivity, reproducibility of results, and clinical performance of five PCR assays for detecting Chlamydia pneumoniae DNA in peripheral blood mononuclear cells.
- Authors: Mahony JB, Chong S, Coombes BK, Smieja M, Petrich A
- Issue date: 2000 Jul
- Replicate PCR testing and probit analysis for detection and quantitation of Chlamydia pneumoniae in clinical specimens.
- Authors: Smieja M, Mahony JB, Goldsmith CH, Chong S, Petrich A, Chernesky M
- Issue date: 2001 May
- Reliability of nested PCR for the detection of Chlamydia pneumoniae in carotid artery atherosclerosis.
- Authors: Apfalter P, Hammerschlag MR, Boman J
- Issue date: 2003 Jul
- Comparison of a new quantitative ompA-based real-Time PCR TaqMan assay for detection of Chlamydia pneumoniae DNA in respiratory specimens with four conventional PCR assays.
- Authors: Apfalter P, Barousch W, Nehr M, Makristathis A, Willinger B, Rotter M, Hirschl AM
- Issue date: 2003 Feb
- Development and evaluation of real-time PCR-based fluorescence assays for detection of Chlamydia pneumoniae.
- Authors: Tondella ML, Talkington DF, Holloway BP, Dowell SF, Cowley K, Soriano-Gabarro M, Elkind MS, Fields BS
- Issue date: 2002 Feb